Vdyne is set to launch a pivotal trial for its transcatheter tricuspid valve replacement system, aiming to address severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results